Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease

Parkinson's disease can affect not only motor functions but also cognitive abilities, leading to cognitive impairment. One common issue in Parkinson's disease with cognitive dysfunction is the difficulty in executive functioning. Executive functions help us plan, organize, and control our...

Full description

Saved in:
Bibliographic Details
Published in:Neural regeneration research Vol. 19; no. 8; pp. 1759 - 1767
Main Authors: Zhou, Zihang, Yan, Yalong, Gu, Heng, Sun, Ruiao, Liao, Zihan, Xue, Ke, Tang, Chuanxi
Format: Journal Article
Language:English
Published: India Medknow Publications & Media Pvt. Ltd 01-08-2024
Department of Neurobiology,Xuzhou Key Laboratory of Neurobiology,Xuzhou Medical University,Xuzhou,Jiangsu Province,China
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Parkinson's disease can affect not only motor functions but also cognitive abilities, leading to cognitive impairment. One common issue in Parkinson's disease with cognitive dysfunction is the difficulty in executive functioning. Executive functions help us plan, organize, and control our actions based on our goals. The brain area responsible for executive functions is called the prefrontal cortex. It acts as the command center for the brain, especially when it comes to regulating executive functions. The role of the prefrontal cortex in cognitive processes is influenced by a chemical messenger called dopamine. However, little is known about how dopamine affects the cognitive functions of patients with Parkinson's disease. In this article, the authors review the latest research on this topic. They start by looking at how the dopaminergic system, is altered in Parkinson's disease with executive dysfunction. Then, they explore how these changes in dopamine impact the synaptic structure, electrical activity, and connection components of the prefrontal cortex. The authors also summarize the relationship between Parkinson's disease and dopamine-related cognitive issues. This information may offer valuable insights and directions for further research and improvement in the clinical treatment of cognitive impairment in Parkinson's disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Both authors contributed equally to this work.
Author contributions: Literature search and manuscript writing: ZZ, YY, CT and RS; figure preparation: ZZ, YY, HG and ZL; manuscript revision: CT, HG and KX; review supervision and outline design: CT. All authors approved the final version of the manuscript.
ISSN:1673-5374
1876-7958
DOI:10.4103/1673-5374.389631